ILL LEG Insurer Cancer Genetic Tests


On May 22, ILL LEG passed bill to cover insured with cancer in family.


  • ILL LEG passed SB 2697 re genetic test, screening for cancer-causing gene mutations.
  • Create ILL INS 215-5-356u.10 (genetic testing and evidence-based cancer screening).
  • Key Bill Provisions
  • Revise Insurance Code to cover tests/screening for those with family history of cancer.
  • Require insurers cover clinical genetic testing for inherited gene mutations associated with increased risk of cancer for those policyholders with cancer in their family history.
  • Total amount insured is required to pay for the clinical genetic test cannot exceed $50.
  • Tests that are positive shall include coverage for screenings, subject to a deductible.
  • Applies to group policy accident or group policy health insurance plans or to managed care plans that are amended, delivered, issued, or renewed after Thurs., Jan. 1, 2026.
  • Legislative History
  • On Jan. 10, 2024, bill was introduced in Senate; on Apr. 10, 2024, bill passed Senate.
  • On Apr. 11, 2024, bill introduced in the House; on May 22, 2024, bill passed in House.
  • Effectiveness
  • If enacted, provisions established in bill SB 2697 effective on Wed., Jan. 1, 2025.
  • Aug. 2024 ILL LEG Reported Approved
  • On Aug. 9, 2024, ILL LEG reported governor approved bill as Public Act 103-0914.

Regulators ILL LEG
Entity Types CNSM; Ins
Reference PA 103-0914, 8/9/2024; Bill, SB2697, 5/22/2024; Citation: ILL INS 215-5;
Functions Claims/Accelerated Benefits; Compliance; Legal; Product Administration
Countries United States of America
Category
State
Products Accident; Critical Illness; Insurance; Insurance-Health
Regions Am
Rule Type Final
Rule Date 5/22/2024
Effective Date 1/1/2025
Rule Id 213035
Linked to N/A
Reg. Last Update 8/9/2024
Report Section US Insurance

Last substantive update on 08/14/2024